| New from NCI |
| Facebook Watch Party: Coping with Your Child’s Cancer Diagnosis |
 | | Meet us on the NCI Facebook page on Wednesday, September 23, at 3:00 p.m. ET to watch and discuss videos from our new series for parents whose children have cancer. NCI experts will answer questions during the event. |
| Video—When Your Child Is Diagnosed with Cancer |
 | | Hear from parents whose children have been diagnosed with cancer. Learn how they moved forward after the diagnosis and found a hospital with expertise in treating children. |
Are People with Cancer Getting the Opioids They Need to Control Pain?
Efforts to contain the opioid epidemic may be keeping older people with cancer from receiving the medicine they need to manage their cancer pain. |
| NCI Annual Plan & Budget Proposal for Fiscal Year 2022 |
 | | Each year, NCI prepares a plan for advancing cancer research and proposes the budget required to fund a broad research portfolio, support the cancer research workforce, and sustain the infrastructure that makes rapid progress against cancer possible. |
Updated Cervical Cancer Screening Guidelines Explained
The American Cancer Society recently updated its recommendations for cervical cancer screening. NCI’s Dr. Nicolas Wentzensen explains how the guidelines have changed. |
Pazopanib Shows Promise for Soft Tissue Sarcomas
Early results from a clinical trial show that adding pazopanib (Votrient) to treatment for advanced soft tissue sarcoma in adults and children may help kill tumor cells before surgery. Learn more about the findings and how pazopanib works.
|
| FDA Approvals |
New Drug for Multiple Myeloma
We’ve added a new drug summary for belantamab mafodotin-blmf (Blenrep). It was recently approved by the Food and Drug Administration to treat multiple myeloma that has come back or does not respond to treatment. It is used in adults who have received at least four previous treatments. |
No hay comentarios:
Publicar un comentario